Jaffe GJ - Search Results

1

Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.

Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Among authors: jaffe gj. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.

2

Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation.

Jaffe GJ, Burton TC, Kuhn E, Prescott A, Hartz A. Jaffe GJ, et al. Am J Ophthalmol. 1992 Oct 15;114(4):448-56. doi: 10.1016/s0002-9394(14)71857-4. Am J Ophthalmol. 1992. PMID: 1415456

3

Tissue plasminogen activator for postvitrectomy fibrin formation.

Jaffe GJ, Abrams GW, Williams GA, Han DP. Jaffe GJ, et al. Ophthalmology. 1990 Feb;97(2):184-9. doi: 10.1016/s0161-6420(90)32618-0. Ophthalmology. 1990. PMID: 2109297

4

Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation.

Williams DF, Bennett SR, Abrams GW, Han DP, Mieler WF, Jaffe GJ, Williams GA. Williams DF, et al. Among authors: jaffe gj. Am J Ophthalmol. 1990 May 15;109(5):606-7. doi: 10.1016/s0002-9394(14)70700-7. Am J Ophthalmol. 1990. PMID: 2110416 No abstract available.

5

Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.

Jaffe GJ, Lewis H, Han DP, Williams GA, Abrams GW. Jaffe GJ, et al. Am J Ophthalmol. 1989 Aug 15;108(2):170-5. doi: 10.1016/0002-9394(89)90013-5. Am J Ophthalmol. 1989. PMID: 2502924

6

Photoablation of ocular melanoma with a high-powered argon endolaser.

Jaffe GJ, Mieler WF, Burke JM, Williams GA. Jaffe GJ, et al. Arch Ophthalmol. 1989 Jan;107(1):113-8. doi: 10.1001/archopht.1989.01070010115038. Arch Ophthalmol. 1989. PMID: 2910269

7

Intravitreal clearance of tissue plasminogen activator in the rabbit.

Jaffe GJ, Green GD, McKay BS, Hartz A, Williams GA. Jaffe GJ, et al. Arch Ophthalmol. 1988 Jul;106(7):969-72. doi: 10.1001/archopht.1988.01060140115036. Arch Ophthalmol. 1988. PMID: 3134000

8

Ab interno sclerostomy with a high-powered argon endolaser.

Jaffe GJ, Williams GA, Mieler WF, Radius RL. Jaffe GJ, et al. Am J Ophthalmol. 1988 Oct 15;106(4):391-6. doi: 10.1016/0002-9394(88)90872-0. Am J Ophthalmol. 1988. PMID: 3177554

9

Binding, coupling, and mRNA subtype heterogeneity of alpha 1-adrenergic receptors in cultured human RPE.

Moroi-Fetters SE, Earley O, Hirakata A, Caron MG, Jaffe GJ. Moroi-Fetters SE, et al. Among authors: jaffe gj. Exp Eye Res. 1995 May;60(5):527-32. doi: 10.1016/s0014-4835(05)80067-3. Exp Eye Res. 1995. PMID: 7615018

10

Treatment and pathogenesis of traumatic chorioretinal rupture (sclopetaria).

Martin DF, Awh CC, McCuen BW 2nd, Jaffe GJ, Slott JH, Machemer R. Martin DF, et al. Among authors: jaffe gj. Am J Ophthalmol. 1994 Feb 15;117(2):190-200. doi: 10.1016/s0002-9394(14)73076-4. Am J Ophthalmol. 1994. PMID: 8116747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters